BSX : Insider Transactions for Boston Scientific Corp

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Boston Scientific Corp (BSX)

$74.98

0.19 (0.25%) as of 4:30 Wed 5/29

Download

Exchange:

New York Stock Exchange

Security Type:

Common

Shares Out:

1,430,000,000

Market Cap:

107.22(B)

Last Volume:

6,809,502

Avg Vol:

8,429,684

52 Week Range:

$48.64 - $75.67

Level I Sector:

Health Care

Level II Sector:

Health Services

Level III Sector:

Medical Instruments & Supplies

Member Indexes:

	S&P COMPOSITE 1500		NYSE COMPOSITE
	S&P 500

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 297

Guru Rank Value : 4.1

Guru Occurances : 2


6 Months 1 Year 2 Year

Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	241,206	430,874	929,865	2,041,378
Total Sell Value	$17,733,804	$29,055,549	$55,374,067	$104,875,147
Total People Sold	8	10	11	13
Total Sell Transactions	13	25	42	77
End Date	2024-02-29	2023-11-28	2023-05-30	2022-05-30

Adjust Filter Settings

Records found: 1831

Page 36 of 74

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Nicholas Peter M

Director

– • –

2010-07-30

$5.59

$139,798

I/I

(25,000)

7,681,021

Abele John E

Director

– • –

2010-07-30

$5.59

$279,655

I/I

(50,000)

554,200

Fitzgerald Joseph Michael

SVP & President, Endovascular

• – –

2010-07-29

$5.60

$12,214

D/D

(2,181)

40,432

Fitzgerald Joseph Michael

SVP & President, Endovascular

• – –

2010-07-29

$0.00

D/D

6,667

42,613

Abele John E

Director

– • –

2010-07-29

$5.63

$281,430

I/I

(50,000)

604,200

Onuscheck John Michael

SVP & Pres-Neuromodulation

• – –

2010-07-29

$5.60

$8,562

D/D

(1,529)

27,002

Onuscheck John Michael

SVP & Pres-Neuromodulation

• – –

2010-07-29

$0.00

D/D

4,167

28,531

Nicholas Peter M

Director

– • –

2010-07-29

$5.62

$140,583

I/I

(25,000)

7,706,021

Abele John E

Director

– • –

2010-07-28

$5.79

$289,605

I/I

(50,000)

654,200

Nicholas Peter M

Director

– • –

2010-07-28

$5.80

$144,945

I/I

(25,000)

7,731,021

Nicholas Peter M

Director

– • –

2010-07-27

$5.93

$148,330

I/I

(25,000)

7,756,021

Abele John E

Director

– • –

2010-07-27

$5.93

$296,400

I/I

(50,000)

704,200

Nicholas Peter M

Director

– • –

2010-07-26

$5.95

$148,703

I/I

(25,000)

7,781,021

Abele John E

Director

– • –

2010-07-26

$5.94

$445,743

I/I

(75,000)

754,200

Abele John E

Director

– • –

2010-07-23

$5.93

$372,321

I/I

(62,749)

829,200

Nicholas Peter M

Director

– • –

2010-07-23

$5.93

$148,358

I/I

(25,000)

7,806,021

Nicholas Peter M

Director

– • –

2010-07-22

$6.04

$151,110

I/I

(25,000)

7,831,021

Abele John E

Director

– • –

2010-07-22

$6.03

$452,515

I/I

(75,000)

891,949

Nicholas Peter M

Director

– • –

2010-07-21

$6.04

$150,978

I/I

(25,000)

7,856,021

Abele John E

Director

– • –

2010-07-21

$6.02

$451,893

I/I

(75,000)

966,949

Abele John E

Director

– • –

2010-07-20

$6.10

$459,003

I/I

(75,000)

1,041,949

Nicholas Peter M

Director

– • –

2010-07-20

$6.10

$152,598

I/I

(25,000)

7,881,021

Abele John E

Director

– • –

2010-07-19

$6.09

$457,438

I/I

(75,000)

1,116,949

Nicholas Peter M

Director

– • –

2010-07-19

$6.11

$152,718

I/I

(25,000)

7,906,021

Abele John E

Director

– • –

2010-07-16

$6.22

$467,725

I/I

(75,000)

1,191,949

1831 Records found	Previous 30 31 32 33 34 35 36 37 38 39 Next	Page 36 of 74

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: